Actualités Genetic Technologies Ltd - GENE | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention

MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

MELBOURNE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REPORT OF...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REPORT OF FOREIGN...

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ:...

Genetic Technologies Provides Update on US Operations and Payer Engagement

MELBOURNE, Australia, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ:...

GENE Momentum building - a year in review

MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

Annual and Transition Report (foreign Private Issuer) (20-f)

0001166272 false FY

Gene achieves key milestones and growth

MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REPORT OF FOREIGN...

GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians

MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REPORT OF FOREIGN...

EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage

MELBOURNE, Australia, July 05, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

GeneType Risk Assessment Test onboarding in 16 clinics

MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Genetic Technologies Ltd (GENE)

Outils de qualité professionnelle, pour des investisseurs individuels.

GENE Actualités

Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Genetic Technologies Provides Update on US Operations and Payer Engagement

GENE Momentum building - a year in review

Annual and Transition Report (foreign Private Issuer) (20-f)

Gene achieves key milestones and growth

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage

GeneType Risk Assessment Test onboarding in 16 clinics

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Genetic Technologies Ltd (GENE) Actualités

Genetic Technologies Ltd (GENE)

Outils de qualité professionnelle, pour des investisseurs individuels.

GENE Actualités

Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Genetic Technologies Provides Update on US Operations and Payer Engagement

GENE Momentum building - a year in review

Annual and Transition Report (foreign Private Issuer) (20-f)

Gene achieves key milestones and growth

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage

GeneType Risk Assessment Test onboarding in 16 clinics

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités